Biosyntia Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $17.3M

  • Investors
  • 11

Biosyntia General Information

Description

Developer of a fermentation-based platform intended to produce natural active ingredients for various applications. The company offers a proprietary process that utilizes unique microorganisms to create high-purity vitamins and bioactives, minimizing environmental impact through reduced chemical waste and land use, enabling businesses in the nutraceutical and personal care sectors to meet consumer demand for sustainable products while ensuring quality and traceability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fruebjergvej 3, boks 54
  • 2100 Copenhagen
  • Denmark
Primary Industry
Biotechnology
Other Industries
Multi-line Chemicals
Vertical(s)
FoodTech, LOHAS & Wellness, Climate Tech, Life Sciences
Corporate Office
  • Fruebjergvej 3, boks 54
  • 2100 Copenhagen
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosyntia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 30-Sep-2022 $17.3M Completed Generating Revenue
6. Later Stage VC (Series A) 23-May-2018 Completed Generating Revenue
5. Seed Round 21-May-2015 Completed Generating Revenue
4. Grant 01-Dec-2013 Completed Startup
3. Grant 01-Jun-2013 Completed Startup
2. Grant 01-Nov-2012 $145K Completed Startup
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Biosyntia’s complete valuation and funding history, request access »

Biosyntia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 39,297 $23.74 $23.74 1x $23.74 4.9%
Ordinary 29,333 $24.99 $24.99 1x $24.99 3.66%
To view Biosyntia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biosyntia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a fermentation-based platform intended to produce natural active ingredients for various applications. The
Biotechnology
Copenhagen, Denmark
21 As of 2024

Boulder, CO
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosyntia Competitors (13)

One of Biosyntia’s 13 competitors is DMC (Biotechnology), a Venture Capital-Backed company based in Boulder, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DMC (Biotechnology) Venture Capital-Backed Boulder, CO
Geno (Biotechnology) Venture Capital-Backed San Diego, CA
Lygos Venture Capital-Backed Hayward, CA
Codexis Formerly VC-backed Redwood City, CA
P e G Supermercados - Garopaba Corporation Garopaba, Brazil
You’re viewing 5 of 13 competitors. Get the full list »

Biosyntia Patents

Biosyntia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4370653-A2 Microbial cell factories producing vitamin b compounds Pending 16-Jul-2021
US-20240368659-A1 Microbial cell factories producing vitamin b compounds Pending 16-Jul-2021
EP-4168566-A1 Methods for producing biotin in genetically modified microorganisms Pending 18-Jun-2020
US-20220127311-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Pending 16-Jan-2019
EP-3911666-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Pending 16-Jan-2019 C07K14/245
To view Biosyntia’s complete patent history, request access »

Biosyntia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosyntia Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Denmark's Export and Investment Fund Venture Capital Minority
ECBF Management Venture Capital Minority
Praesidium (Luxembourg) Asset Manager Minority
Sofinnova Partners Venture Capital Minority
European Union Seventh Framework Programme Government
You’re viewing 5 of 11 investors. Get the full list »

Biosyntia FAQs

  • When was Biosyntia founded?

    Biosyntia was founded in 2012.

  • Where is Biosyntia headquartered?

    Biosyntia is headquartered in Copenhagen, Denmark.

  • What is the size of Biosyntia?

    Biosyntia has 21 total employees.

  • What industry is Biosyntia in?

    Biosyntia’s primary industry is Biotechnology.

  • Is Biosyntia a private or public company?

    Biosyntia is a Private company.

  • What is the current valuation of Biosyntia?

    The current valuation of Biosyntia is .

  • What is Biosyntia’s current revenue?

    The current revenue for Biosyntia is .

  • How much funding has Biosyntia raised over time?

    Biosyntia has raised $24M.

  • Who are Biosyntia’s investors?

    Denmark's Export and Investment Fund, ECBF Management, Praesidium (Luxembourg), Sofinnova Partners, and European Union Seventh Framework Programme are 5 of 11 investors who have invested in Biosyntia.

  • Who are Biosyntia’s competitors?

    DMC (Biotechnology), Geno (Biotechnology), Lygos, Codexis, and P e G Supermercados - Garopaba are some of the 13 competitors of Biosyntia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »